CSF3 and type 1 diabetes mellitus: Indeed, we previously reported that low dose mATG in combination with granulocyte colony stimulating factor (G-CSF) treatment leads to durable reversal of diabetes in NOD mice [3] and, more recently, that the same therapy preserves beta cell function in patients with established T1D [4].